During the past decade, Euromedica Kyanous Stavros General Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Euromedica Kyanous Stavros General Hospital" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Horizon Therapeutics Ireland DAC" with 2 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Medtronic Cardiovascular" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Euromedica Kyanous Stavros General Hospital" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Euromedica Kyanous Stavros General Hospital" are "Systemic Lupus Erythematosus" (3 trials), "Aortic Aneurysm, Abdominal" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Diffuse Cutaneous Systemic Sclerosis" (1 trials). Many other conditions were trialed in "Euromedica Kyanous Stavros General Hospital" in a lesser frequency.

Most popular intervention types in "Euromedica Kyanous Stavros General Hospital" are "Drug" (7 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Baricitinib" (2 trials), "Avastin" (1 trials), "BI 695502" (1 trials) and "Daxdilimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Euromedica Kyanous Stavros General Hospital" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Euromedica Kyanous Stavros General Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Euromedica Kyanous Stavros General Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Euromedica Kyanous Stavros General Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".